Alternatives to Sumondo

BetterYou is an innovative platform that leverages artificial intelligence to enhance employee wellness, aiming to elevate overall health, diminish burnout, and increase productivity through scientifically-backed nudges and behavioral insights. Focusing on crucial aspects like physical activity, social engagement, and sleep quality, it facilitates measurable enhancements in users' lives. Participants typically see a rise in their daily step counts by approximately 500 steps, enjoy an additional 10 minutes of meaningful social interaction weekly, and experience an increase of around 30 minutes of sleep per night. The platform seamlessly integrates into existing corporate wellness initiatives, featuring automatic tracking that eliminates the need for manual data entry, as well as mission-driven challenges designed to boost engagement. Organizations employing BetterYou often report significant decreases in risks associated with high blood pressure, obesity, diabetes, heart disease, anxiety, depression, and feelings of loneliness among their employees. Furthermore, BetterYou adheres to HIPAA and SOC 2 compliance standards, thereby assisting organizations in effectively managing healthcare claims and mitigating various risks by prioritizing wellness at the enterprise level. Ultimately, the platform not only enhances individual well-being but also cultivates a healthier workplace culture.

Today, 100Plus stands as the fastest-growing platform for remote patient monitoring, uniquely available at no expense to both you and your patients. Catering to a wide range of health conditions, including heart disease, varying blood pressures, congestive heart failure, diabetes, and obesity, 100Plus ensures a quick implementation process that allows you to be operational within minutes while delivering devices directly to your patients' homes. With their White-Glove Enrollment service, 100Plus excels in efficiently onboarding any number of patients, from 10 to 10,000, by providing essential outreach and educational resources. Their Predictive Population Health Management™ system diligently monitors your patients’ health data and promptly alerts you for timely interventions, thereby aiding in the prevention of episodic care scenarios. The platform offers integrated cellular devices without any monthly fees or bills, including a Blood Pressure Cuff, Blood Glucose Monitor, Digital Weight Scale, Emergency Watch, Digital Thermometer, and Pulse Oximeter. Additionally, 100Plus provides exceptional support with their White Glove setup, which encompasses patient outreach, education, and enrollment services, along with reliable product assistance available from 9 AM to 9 PM ET through phone and online chat, ensuring you and your patients receive the help you need whenever it is required.

Behavioral health constitutes a crucial yet frequently neglected component of overall wellness. The impact of mental and substance use disorders affects an astonishing 970 million individuals globally, contributing to an economic burden exceeding US $1 trillion each year. In spite of this escalating crisis, advancements in treatment and understanding have not kept pace with other medical fields. Alarmingly, less than half of those suffering from major depression, which is the most prevalent mental health disorder, achieve remission with existing therapies. Increased awareness has sparked a greater demand for services in a system that remains ill-equipped to address the extensive complexities of this need. There exists a significant evidence gap that hinders progress in research and innovation, largely due to the inherent challenges within behavioral health, such as intricate disease causes, a shortage of measurable biomarkers, and fragmented institutional approaches. Even after many years of dedicated research, we remain largely in the dark about how to effectively treat most behavioral health conditions, indicating a critical need for renewed focus and resources in this field. Ultimately, bridging this gap is essential for improving the lives of millions affected by these disorders.

The microbiome plays a significant role in various diseases and health issues. Discover how Kaleido is pioneering a unique method to transform the potential of the microbiome into effective patient solutions. Comprising over 30 trillion microbes, the human microbiome includes a diverse array of organisms such as bacteria, viruses, archaea, and fungi that inhabit both the exterior and interior of the human body. In recent years, there has been a remarkable surge in research focusing on the microbiome's influence on human health, linking it to conditions such as cardiovascular disease, cancer, diabetes, Parkinson’s disease, and allergies. This intricate microbial community has been likened to a "newly discovered organ," highlighting its significance. Just as many human organs command substantial investments for therapies that modify physiology, the microbiome represents a largely unexplored territory in the realm of healthcare. Addressing this frontier could unlock new therapeutic avenues and enhance overall health outcomes.

Fitterfly is a health technology enterprise focused on metabolic wellness, utilizing innovative, customized technology and scientific principles to assist individuals in managing conditions like diabetes, obesity, heart disease, and other metabolic issues. Their offerings, including Fitterfly Diabetes Prime and Fitterfly Weight Loss, present thorough and tailored strategies that feature real-time blood glucose monitoring through a non-invasive Continuous Glucose Monitoring (CGM) device, as well as personalized plans for diet, exercise, stress management, and sleep, all complemented by dedicated health coaches. These initiatives aim to empower individuals to reach significant health milestones with results that genuinely impact their lives. Fitterfly’s methodology is anchored in rigorous behavioral therapy, emphasizing the cultivation of healthy habits through a focus on nutrition, physical activity, stress reduction, and sleep hygiene. Their digital therapeutic solutions are clinically validated, demonstrating successful outcomes such as an average decrease of 1.96 points in HbA1c levels within three months, alongside an average weight reduction of 5 kg, showcasing the effectiveness of their programs in promoting overall health. Ultimately, Fitterfly strives to transform the way people approach their metabolic health through a blend of technology and personalized care.

Digital Care Made Human™. Omada® enables individuals to reach their health aspirations through enduring lifestyle modifications. Our all-encompassing digital care ensures that engaging in various programs is simple, as we provide your workforce with round-the-clock, tailored support to meet their unique health requirements. Prediabetes Prevention: An alarming 1 in 3 Americans is affected by prediabetes. With Omada’s Prevention program, participants can expect a 30% reduction in the risk of Type 2 Diabetes and a 13% decrease in heart disease risk. On average, those who complete the program shed around 4-5% of their body weight and maintain this loss over time. Diabetes Management: A concerning 46% of diabetes patients fail to achieve proper glycemic control (A1C < 7%). In Omada’s Diabetes program, 92% of participants express satisfaction, and those who were not meeting their goals saw an A1C reduction of over 1%. Additionally, with Hypertension affecting 46% of the US population, our programs are designed to address this significant health challenge effectively. Our commitment to ongoing support ensures that individuals can take charge of their health journey with confidence.

Mahalo Health is an integrated digital health platform aimed at expediting the creation of patient-focused digital health solutions and clinical trials. By providing a variety of prebuilt modules, Mahalo facilitates the swift launch of customizable white-label applications that cater to particular therapeutic fields. The platform boasts comprehensive data capabilities, featuring a predictive health engine for forecasting diseases and diagnoses, a behavior modification engine to encourage beneficial patient behaviors, and a notification system that ensures timely communication through push notifications, SMS, or emails. Committed to maintaining high security and compliance standards, Mahalo follows regulations such as HIPAA, GCP, ISO27001, and GDPR. Its extensive range of services encompasses multiple therapeutic areas, including diabetes, cognitive health, cardiovascular issues, musculoskeletal conditions, mental health, oncology, rare diseases, and nonalcoholic steatohepatitis (NASH). Additionally, Mahalo Health empowers healthcare providers with tools to enhance patient engagement and outcomes through its innovative digital solutions.

Elevate the effectiveness of value-based care through the OMS Trace Analytics® cloud platform, which specializes in the analysis and reporting of essential cardiovascular metrics. As reimbursement increasingly hinges on value, it's important to note that in the 2018 performance year, 60% of Medicare reimbursements were associated with quality metrics under the Quality Payment Program. This emphasizes the growing necessity for a precise data-driven and evidence-based quality reporting solution aimed at measuring, targeting, and enhancing your quality initiatives. The OMS Trace Analytics® cloud platform is expertly crafted to provide profound clinical insights into cardiovascular conditions, featuring dedicated dashboards that focus on key cardiovascular issues such as Hypertension, Dyslipidemia, Atrial Fibrillation, Heart Failure, Coronary Artery Disease, and Peripheral Artery Disease. With the integration of such advanced analytics, healthcare providers can better navigate the complexities of value-based care while actively improving patient outcomes.

Dexur compiles claims data from diverse sources and, by leveraging advanced algorithms, offers a range of insights to organizations within the Life Sciences sector, such as those involved in Sales and Marketing, Disease Burden Data, HEOR & RWE, and Patient Journey analysis. By utilizing its anonymized claims database, Dexur creates comprehensive dashboards and disease burden data at multiple levels, including national, regional, and hospital scales. Insights pertaining to specific diseases, such as Diabetes and Chronic Kidney Disease, encompass metrics like total cost of care, readmission rates, mortality figures, nursing home expenses, length of hospital stays, and other disease-specific indicators. The Life Sciences App Suite from Dexur provides valuable insights into various financial and clinical quality metrics, facilitating in-depth analysis of Hospitals, Ambulatory Surgery Centers (ASCs), Providers, and Integrated Delivery Networks (IDNs). This strategic approach enables life sciences companies to effectively tailor their products and services to the most appropriate clientele, ultimately enhancing their market reach and impact. By streamlining their targeting efforts, these organizations can optimize resource allocation and improve patient outcomes.

For those managing a fitness center or overseeing the health and wellness of a large community, effective information management is crucial to achieving your goals. This is where HealthCalc 2000 comes into play as an essential, cost-effective, and time-efficient tool. Designed specifically for health and fitness professionals and facilities, HealthCalc 2000 is a comprehensive suite of Windows® based software. It streamlines various tasks such as conducting fitness assessments, managing front desk operations, and tracking program participation with impressive speed and accuracy. The software allows you to administer tests that measure aerobic capacity, body composition, strength, endurance, and flexibility. Additionally, it generates tailored exercise prescriptions and evaluates significant health risk factors like cholesterol levels, blood pressure, lifestyle choices, and stress management. By calculating the risks associated with coronary heart disease and stroke, HealthCalc 2000 also provides valuable summaries and recommendations, ultimately enhancing the health outcomes of your clients. It serves as an indispensable resource for anyone committed to promoting fitness and well-being in their community.

Diagnosis refers to the process of determining what disease or condition is causing a person's symptoms and test results. DDxHub – Differential diagnosis Hub is a system that distinguishes a specific disease or condition from others with similar symptoms and lab results. DDxHub is a concentrator which holds a lot disease descriptions. DDxHub can be useful when you are trying to find the right diagnosis by comparing multiple diagnoses. You can upload your own disease definition to DDxHub repository, and then share it with other DDxHub users worldwide. You will receive disorder descriptions from other DDxHub users in return. Join thousands of healthcare professionals and patients who already love DDxHub’s differential diagnosis, sync, disorders description sharing solution. DDxHub can be used by medical students in clinical therapeutics as an educational resource.

Introducing a comprehensive remote patient monitoring solution designed to benefit all users. Verustat provides precise care for your patients, streamlines your team's workload, and enhances your financial performance. Our innovative at-home monitoring system ensures that your patients are closely observed, similar to how you would do it yourself. With daily evaluations conducted by our remote care coordinators, we assist in maintaining patient compliance while also facilitating your eligibility for reimbursement. Our team consistently monitors your patients, and our HIPAA-compliant online portal and app give you seamless access to the most current biometric data. We support the management of various health conditions, including hypertension, obesity, stroke, coronary artery disease, COPD, and diabetes, among others. To further aid your patients, we provide top-tier connected devices such as blood pressure monitors, glucometers, pulse oximeters, and scales, delivered straight to their homes. This approach ensures a more proactive and engaged healthcare experience for both providers and patients alike.

Individuals globally are plagued by intricate illnesses and a wide array of symptoms. Yet, they all have one crucial requirement in common: the urgent demand for the quicker creation of safer and more efficient treatments. Owkin’s goal is to enable researchers in hospitals, universities, and pharmaceutical firms to comprehend the reasons behind variations in drug effectiveness among patients, streamline the drug development process, and pinpoint the optimal medication for each individual to enhance therapeutic results. Central to Owkin's research ecosystem is Owkin Loop, which links medical researchers with high-quality datasets sourced from top academic research institutions worldwide. This innovative platform is driven by two primary elements of Owkin's Software Stack: Owkin Studio, a machine learning platform, and Owkin Connect, which serves as a federated learning framework. Additionally, Owkin is actively engaged in medical research collaborations across various fields, including Oncology, Immunology, and Cardiovascular diseases, showcasing the breadth of its commitment to improving patient care. Their collaborative efforts reflect a dedication to transforming healthcare through advanced technology and data-driven insights.

Cardiovascular diseases result in more than 20 million fatalities globally each year, many of which could be avoided through timely detection. Unfortunately, the healthcare sector is often stretched thin, hindered by the limitations of human analysis capabilities. This is where AIATELLA makes a significant impact. Our innovative AI-driven image analysis technology revolutionizes cardiovascular diagnostics. By automating the intricate measurements of blood vessels and leveraging historical data, we substantially reduce the time, expenses, and required expertise, thereby enhancing the potential for vital imaging procedures. AIATELLA's approach not only accelerates the diagnostic process but also boosts the precision and reliability of results, providing critical measurements and disease progression insights in mere seconds rather than hours. As a result of this increased efficiency and accuracy in analyses, healthcare providers can dedicate more time to patient care, ultimately paving the way for effective preventative strategies and personalized treatment options for everyone. This shift could redefine how we approach cardiovascular health on a global scale.

If you're only interested in counting steps and earning points to redeem into prizes, we're not for you. Our focus is solely on what truly impacts your health. If you want to genuinely improve your health and productivity, you can continue reading. Myworkout is not just some app or wellness program. We offer three decades of rigorous research into the beneficial effects of exercise on health, aging, and disease prevention, we've crafted an unparalleled wellness solution. We offer No fluff. No gimmicks. Just fuzz-free measurable results on your employees health. We’re in the business of transformation, offering a proven success formula that rejuvenates the biological age by 7 years, improves productivity by 5%, and reduces sick leaves by 3.5 days on average. Do you have any idea how much money you're potentially saving? No matter the size of your business, Myworkout is a healthy decision that pays dividends in workforce vitality.

When individuals are dealing with a common cold or managing long-term illnesses such as diabetes or heart disease, they frequently have inquiries and concerns that require attention, as well as guidance to help ensure they comprehend and stick to their treatment plans. Health Dialog presents a collection of tailored population health solutions designed to tackle these challenges, empowering your members to enhance their overall health while simultaneously decreasing costs. Our team of healthcare professionals provides personalized health coaching through targeted outreach to assist members in better managing chronic conditions, including asthma, diabetes, and heart disease. We pinpoint members who may be at risk of not following their treatment plans, identify the most effective ways to engage them, and offer education to promote consistent medication adherence. Additionally, your members can benefit from round-the-clock access to a live registered nurse who is available to deliver clinical advice, refer them to necessary services, teach vital skills, and provide pertinent educational resources to support their health journey. This comprehensive approach not only enhances member engagement but also fosters a more informed and health-conscious community.

Enhance patient care by using the only objective, quantitative arterial analysis software validated through histology and based on CTA technology. This innovative tool employs ground-truth histological data to reveal the origins of myocardial ischemia, helping to assess risks for heart attacks and strokes. These critical events are often driven by unstable, non-obstructive plaques within the arteries that remain undetected and unaddressed. Traditional non-invasive diagnostic methods fall short, as they cannot penetrate deep into the arterial walls where heart disease begins to manifest. Elucid is leveraging advanced scientific imaging alongside artificial intelligence to facilitate rapid, reliable, and non-invasive diagnoses, ultimately leading to tailored treatment strategies for cardiovascular conditions and improved patient outcomes. With this histology-validated software, you can evaluate plaque composition and determine the risks of heart attacks and strokes with unmatched precision. This comprehensive, objective visualization of arterial health empowers healthcare providers to devise customized treatment approaches well before a patient arrives for hospital care, significantly enhancing the quality of healthcare delivery.

Cleerly is a pioneering digital health organization that is revolutionizing how healthcare professionals manage heart disease. Our innovative clinical technologies are designed to enable clinicians to detect and accurately characterize atherosclerosis at an earlier stage, allowing for the development of customized and potentially life-saving treatment strategies for patients throughout their healthcare journey. Rather than relying on indirect indicators like risk factors or symptoms, we focus on measuring atherosclerosis directly, which is the accumulation of plaque in the arteries of the heart. By utilizing our AI-driven digital care pathways, we provide streamlined, rapid, and precise diagnostics and reporting that cater to the needs of all stakeholders, leading to enhanced clinical and financial results. Cleerly equips healthcare providers to transcend conventional assessments of heart disease by thoroughly analyzing, characterizing, and quantifying various plaque types. This advanced approach enables clinicians to better assess a patient's likelihood of experiencing a heart attack and to formulate effective treatment plans that aim to enhance overall heart health, ultimately fostering improved patient outcomes and quality of care.

Achieving significant measurable outcomes necessitates a high level of engagement from participants. Personalized baseline evaluations are designed to align with each individual's goals and interests. While some employees are thriving, others may be focused on particular health challenges or are eager to enhance their well-being through increased physical activity, weight loss, stress reduction, improved sleep, and more. There’s no need for an extensive health risk questionnaire; instead, employees can select the modules that resonate with their current needs and dedicate just a few minutes to evaluate their baseline health indicators. The findings are straightforward yet insightful, providing meaningful guidance. Our researchers pioneered the innovative concept of "Cardiovascular Age," which has since been adopted globally. Understanding whether your heart is aging at a faster rate than your chronological age can serve as a powerful motivator, as evidenced by our published research. This approach not only empowers employees to take charge of their health but also fosters a culture of wellness within the organization.

This Screening Tool is designed to assist you in assessing potential COVID-19 symptoms based on the criteria set by the Centers for Disease Control. The recommendations you receive will rely heavily on the accuracy of the details you share, as well as the up-to-date guidelines for identifying COVID-19 symptoms. After you complete the survey, the tool will generate a response that should be communicated to your employer, following their specific instructions. It’s important to note that this tool is not a replacement for professional medical advice, diagnosis, or treatment related to any health conditions, including COVID-19. For any serious symptoms or emergencies, always reach out to a qualified medical professional for assistance. Additionally, staying informed about health guidelines can further enhance your understanding of COVID-19 and its implications.

Identify issues related to plant emergence to inform replanting choices. Monitor for weeds both before they sprout and throughout the growing season to optimize herbicide use. Recognize signs of nutrient deficiencies to evaluate changes in crop health over time. Detect crop pests and diseases to facilitate targeted pesticide applications and safeguard yields. Pinpoint equipment failures that may lead to emergence issues and reduced yield. Assess hydration levels to determine if crops are suffering from drought conditions or overwatering. Utilize our sorting interface and crop progression maps to enhance equipment guidance from planting to harvest. Add long-term value by detecting drainage and tiling issues before they can impact yield negatively. Harness AI technology to accurately identify precise areas of crop stress, enabling more effective scouting and providing reassurance to growers. The innovative AI cognitive decision-making engine has already analyzed vast amounts of crop imaging data across various seasons, demonstrating its intelligence and continuous improvement. With this advancement, farmers can make more informed decisions to enhance their agricultural practices, ultimately leading to better productivity and sustainability.

The Montreal Cognitive Assessment (MoCA) is a concise, 30-item evaluation designed for healthcare professionals to identify cognitive deficits at an early stage, facilitating quicker diagnoses and enhanced patient management. This tool enables both healthcare providers and researchers to recognize cognitive challenges associated with various conditions, including Alzheimer's disease, Parkinson's disease, and several others such as frontotemporal dementia and brain tumors. MoCA is frequently utilized by a diverse range of practitioners, including nurses, primary care doctors, specialists, occupational therapists, and psychologists, among others. It efficiently evaluates critical cognitive functions such as short-term memory, visuospatial skills, executive functioning, attention, and language abilities, as well as orientation to time and place. The versatility of MoCA makes it an essential component of cognitive health assessments across various settings.

Comprehensive recommendations are provided throughout the entire patient journey, ensuring every phase of care is addressed effectively. There is a strong call-to-action that facilitates the monitoring and evaluation of both commercial and clinical outcomes. Disease-specific risk algorithms have been established for conditions such as diabetes, cardiovascular issues, kidney health, and liver health, among other therapeutic areas. A Complete Wellness Score is utilized to evaluate the likelihood of requiring inpatient care. Additionally, proprietary data and established protocols are complemented by user-friendly clinical content tailored for patients. This content is not only ready for immediate use but can also be customized for various purposes and formats. Intelligent decision support is available, leveraging both established protocols and machine learning to analyze prescribers' patterns in medication prescriptions. Furthermore, the most advanced customer feedback system has been custom-designed specifically for healthcare organizations. The system operates on a multi-parameter engine that considers factors such as expenditure, compliance in a timely manner, preventive health checkups, improvements in clinical parameters and outcomes, as well as demographic information, providing a holistic view of patient care and intervention needs. Overall, this approach aims to enhance patient outcomes while streamlining the healthcare process.

Digital programs designed to foster enduring behavioral changes among vulnerable groups can effectively eradicate persistent, health-diminishing habits. Discover how to permanently overcome detrimental behaviors that contribute to chronic diseases. These online cognitive training solutions help mitigate the expensive behavioral health risks faced by employees. Many chronic illnesses stem from six predominant unhealthy habits that are notoriously difficult to overcome due to their emotional underpinnings, which often resist traditional behavior modification strategies. Our cognitive training initiatives target and dismantle the emotional and psychological factors that sustain these harmful habits. Unlike conventional methods, these interventions replicate the experience of personal coaching at a significantly lower price point. The programs include pre-recorded instructional videos led by expert trainers, along with engaging quizzes and multimedia resources, all accessible through a companion app. Participants receive systematic guidance to reach their objectives through a combination of “live” video coaching and interactive content, enhanced by timely notifications to keep them on track. This comprehensive approach ensures that individuals not only understand the changes needed but also have the tools and support to sustain them over time.

Superpower is an all-encompassing digital health platform aimed at empowering individuals to extend their lifespan, avert illnesses, and enhance their overall wellness. By integrating comprehensive body assessments with tailored health initiatives, Superpower offers its users a holistic health membership that encompasses evaluations for hormones, thyroid performance, cardiovascular health, toxins, genetic factors, microbiome composition, cancer susceptibility, and other vital aspects. Each member receives an annual guide that outlines practical measures to improve various dimensions of their health, facilitating a shift from ambiguity to a state of empowerment. The platform also provides access to a dedicated concierge clinician, allowing members to engage via text for support with orders, appointment scheduling, inquiries, and coaching. Furthermore, Superpower boasts a carefully selected marketplace of health-related products, tests, and services available at exclusive prices, with fresh offerings introduced weekly. Customized programs specifically address critical areas such as gut health, hormone balance, aging processes, toxin reduction, disease prevention, and body composition optimization, catering to the unique needs of each individual. With such diverse offerings, Superpower aims to create a supportive environment that fosters long-term health and wellness.

Specialty and rare diseases often encompass patient populations that are not clearly defined, including individuals who remain undiagnosed or face misdiagnoses, along with healthcare providers who may lack knowledge about these conditions and their various manifestations, resulting in treatment pathways that are poorly understood. IPM.ai operates as an Insights-as-a-Service (IaaS) firm, dedicated to empowering leading life sciences organizations to gain deeper insights into patient care and enhance the quality of life for those affected through the development, clinical research, and commercialization of therapeutic solutions. By predicting market size, analyzing the competitive landscape, and estimating potential return on investment, companies can optimize their commercialization strategies. Additionally, the platform identifies undiagnosed and misdiagnosed individuals who could benefit from early disease interception and therapeutic measures. It employs statistical models to gauge the prevalence of specific diseases within certain patient populations at any given moment. Furthermore, IPM.ai helps pinpoint physicians who are adept at diagnosing and treating these ideal patients, while also influencing other healthcare providers to enhance overall patient outcomes. This comprehensive approach ultimately aims to bridge the gap in understanding and addressing the needs of those with rare diseases.

Oncoustics is pioneering the development and application of innovative, patented AI technologies aimed at providing low-cost, non-invasive surveillance, diagnostics, and treatment monitoring for diseases that currently face significant clinical challenges. The company has developed a range of specialized applications focused on various diseases and anatomical structures that are compatible with any point-of-care ultrasound device, allowing physicians, nurses, and technicians to operate them as essential tools in a primary care setting without requiring image analysis. By leveraging AI, Oncoustics transforms affordable point-of-care ultrasound machines into robust diagnostic instruments capable of facilitating quick and economical identification and monitoring of conditions affecting the liver, prostate, kidney, breast, and thyroid. The multidisciplinary team behind Oncoustics consists of professionals with expertise in AI, signal processing, radiology, hepatology, digital health, and ultrasound, ensuring a comprehensive approach to healthcare innovation. The emphasis on cost-effective point-of-care diagnostics and surveillance significantly enhances patient outcomes through timely detection and consistent monitoring, which are crucial for effective disease management and better overall health. As such, Oncoustics is not only addressing immediate healthcare needs but is also setting the stage for a transformation in how we approach disease management in the future.

VSClinical facilitates the clinical analysis of genetic variants in accordance with ACMG and AMP guidelines. Its structured workflow supports adherence to the American College of Medical Genetics (ACMG) standards, which are essential for identifying and categorizing pathogenic variants related to inherited disease risk, cancer susceptibility, and rare disease diagnosis. The combined ACMG/AMP guidelines for variant interpretation establish a framework for scoring variants and categorizing them into one of five classification levels. Implementing these guidelines necessitates a thorough examination of annotations, genomic contexts, and pre-existing clinical insights for each variant. VSClinical streamlines this process by offering a customized workflow that evaluates each relevant criterion and supplies comprehensive bioinformatics, literature references, and clinical knowledgebase evidence to aid in the scoring and interpretation of variants. This innovative approach is designed to enhance the efficiency of variant scientists as they navigate the complexities of variant processing and analysis. Overall, VSClinical stands out as a vital tool for accelerating the understanding and classification of genetic variants in clinical settings.

Enhance your ability to manage risks and deliver superior care to your community through the disease prediction models offered in CARE™. We provide a comprehensive perspective of medical claims data at a national scale, which can be tailored to meet the specific needs of our clients at a granular level. Our sophisticated models sift through billions of medical claims to pinpoint risk indicators for early disease development or the necessity for surgical interventions. Armed with this vital information, healthcare providers can initiate diagnoses and treatments earlier, which has the potential to save lives. While our prediction models are trained on extensive national data, they can also be applied to your own EHR, population health platform, or member claims database for a more personalized approach. Additionally, our physician matching feature aids in aligning patients with the most suitable providers, thereby enhancing their care journey towards optimal treatment outcomes. By utilizing clinically significant data, our advanced disease prediction models identify individuals who are at risk of developing a condition, empowering you to proactively engage with them and commence treatment before the situation escalates. This proactive engagement not only improves patient outcomes but also enhances the overall efficiency of healthcare delivery.

DarioHealth presents an integrated digital health platform aimed at the comprehensive management of chronic conditions over the long term, focusing on areas such as cardiometabolic health (including diabetes, hypertension, and weight), musculoskeletal issues, and mental health. By merging connected consumer devices with a user-friendly mobile application, real-time human coaching, and AI-enhanced behavior modification pathways, the platform adopts a “one platform, one coach, one experience” philosophy. This allows users to effectively track important health metrics like blood glucose levels, blood pressure, body weight, and also monitor their exercise routines, dietary choices, and emotional well-being. Users benefit from tailored interventions that adapt to their evolving health needs, ensuring a personalized journey toward better health. With a foundation built on clinical validation, the platform boasts reported outcomes such as marked improvements in A1c levels, reductions in blood pressure categories, and decreases in BMI, while also addressing pain relief and posture enhancement in musculoskeletal health, alongside alleviation of anxiety and depressive symptoms in mental health. Overall, DarioHealth provides a holistic approach to chronic condition management that empowers users to take charge of their health journey.

Artrya collaborates with healthcare facilities that treat chest pain patients to introduce innovative cardiovascular care models powered by artificial intelligence. This approach seamlessly incorporates high-prognostic plaque characteristics into the assessment of coronary artery disease. It enables swift evaluations of chest pain patients in both emergency and primary care environments. Our vision is a society free from the burden of heart attacks. Leveraging AI-generated insights from coronary computed tomography angiography (CCTA), we can rapidly and accurately classify chest pain patients based on the type and quantity of arterial plaque identified. This allows for quick identification of individuals with little to no coronary artery disease, ensuring that no underlying plaque issues could lead to significant cardiac events in the future. By recognizing early indicators of potential heart attacks, we can effectively confirm at-risk patients with acute or unusual chest pain who may require additional investigation and treatment. Ultimately, this advancement aims to enhance patient outcomes and foster a healthier community.

Sofpromed specializes in providing electronic data capture (EDC) solutions tailored for companies in the biotechnology, pharmaceutical, and medical device sectors involved in clinical trials ranging from phases I to IV. An EDC system serves as a software platform that facilitates the collection, validation, and exportation of data gathered during clinical studies. The EDC software developed by Sofpromed is utilized in clinical trials globally, spanning a diverse range of therapeutic fields such as oncology, hematology, cardiovascular health, metabolic disorders, central nervous system (CNS) issues, dermatology, infectious diseases, respiratory conditions, and pain management, among others. It boasts a user-friendly design that is simple and intuitive, allowing for rapid data entry and easy navigation. The platform also incorporates robust features such as access control and data encryption to ensure data security. Being fully web-based, it eliminates the need for any installations, providing convenience and efficiency. Additionally, it offers daily data backups and uninterrupted service, making it reliable for users. The system is compatible across various devices, browsers, and operating systems, enhancing its accessibility. It includes integrated monitoring, data management, and reporting functionalities, ensuring compliance with HIPAA, GCP, and 21 CFR standards. Furthermore, Sofpromed offers a convenient billing structure with a monthly flat rate, making it a practical choice for clinical trial needs. Overall, its comprehensive features and user-centric design make it an essential tool for conducting efficient and compliant clinical trials.

Recursion is a leading TechBio innovator using artificial intelligence to radically improve how new medicines are discovered and developed. The company was founded on the idea that images of cells could be used to train AI systems to understand disease biology at scale. By combining data, machine learning models, and powerful computing, Recursion works to overcome the inefficiencies of traditional drug discovery. Its Recursion OS platform connects massive proprietary biological datasets with automated experimentation and AI-driven insights. This approach has produced a growing pipeline of potential therapies for oncology and rare diseases with high unmet medical needs. Recursion has demonstrated significant gains in speed, efficiency, and cost reduction compared to conventional pharmaceutical methods. Strategic partnerships with pharmaceutical companies and technology leaders expand the reach of its platform. The company also collaborates with NVIDIA to power its discovery efforts using BioHive-2, one of the most advanced supercomputers in biopharma. Together, these capabilities position Recursion as a leader in AI-driven drug discovery. Its ultimate goal is to deliver better medicines to patients through precision design and data-driven science.

As organizations broaden their onsite clinic services to encompass primary care, urgent care, chronic disease management, and health and wellness offerings, a standard occupational health IT system is insufficient to support this expanded scope. Enterprise Health integrates occupational health and compliance, clinical care, and employee engagement into a single ONC-ACB certified EHR, providing a comprehensive solution that effectively addresses both occupational health and safety as well as corporate wellness initiatives. This platform not only facilitates the tracking and management of health surveillance activities, work-related illnesses and injuries, and clinical services but also encourages employees to take a proactive role in their health, wellness, and compliance. With Enterprise Health’s versatile toolsets, employees can easily communicate with clinical staff and gain electronic access to vital information, enabling them to enhance their own health and that of their families. Furthermore, this integration fosters a culture of wellness within the organization, ultimately leading to improved employee satisfaction and productivity.

An AI-driven solution utilizing X-Ray and CT scans is designed for public health screening, focusing on identifying chest pathologies such as Tuberculosis and COVID-19-related infections. This innovative system, known as Genki, integrates "AI+Expert in the loop" to deliver a comprehensive imaging workflow, where artificial intelligence enhances the capabilities of imaging specialists, resulting in quicker report generation and increased productivity. Utilizing cutting-edge technology, Genki effectively augments X-ray imaging for the analysis of infectious diseases like TB and COVID-19, offering rapid prescreening and triage capabilities. We have meticulously refined the entire workflow to facilitate a seamless process for imaging assessment, diagnosis, and reporting, while a smart notification system alleviates the stress often associated with reporting tasks. Key features of Genki include the ability to classify, localize, and quantify lesions effectively. The solution emphasizes point-of-care diagnostics, which is essential for addressing the gaps in disease elimination, and can be integrated into mobile X-ray units and CT scanners, ensuring immediate triage and prescreening when needed. This approach not only enhances efficiency but also significantly contributes to improving public health outcomes.

ONEai Health provides a state-of-the-art clinical surveillance platform that consolidates biometric information from smart wearables and medical devices to keep track of patients, utilize AI for trend analysis, and send alerts if conditions start to deteriorate. Its innovative BIO-EYE system employs predictive analytics tailored to specific diseases, allowing for the early identification of health declines in individuals suffering from chronic illnesses like congestive heart failure, chronic obstructive pulmonary disease, diabetes, hypertension, and sepsis. This facilitates timely interventions and helps to minimize hospital admissions. The platform integrates real-time vital signs, including heart rate, SpO₂ levels, heart rate variability, stress levels, sleep patterns, and physical activity through tools like Apple HealthKit. Additionally, it offers easy access via a mobile application for patients and ensures secure data sharing with healthcare teams. By consistently monitoring the health progress of patients, ONEai Health empowers clinicians to take earlier action, enhance patient outcomes, reduce healthcare costs, and extend monitoring capabilities into recovery environments, long-term care facilities, and patients' homes, ultimately promoting overall health and well-being.

Ampersand Health implemented an 8-week support initiative aimed at individuals with IBD who suffer from chronic pain and fatigue. Following the completion of the programme, a significant enhancement in the group average scores from the ACT survey was observed (n=21, p<0.0001). These findings indicate that participants were able to foster acceptance and psychological flexibility, gain a deeper understanding of their chronic symptoms, and feel a sense of connection, realizing they can lead a fulfilling life despite the ongoing challenges of pain and fatigue. While the study anticipated no change in the physical levels of chronic pain and fatigue, self-reported outcomes revealed a shift in how symptoms were perceived following participation in the programme. Measurements of symptoms and disease activity, assessed through a validated Patient Reported Outcome Measure, remained stable throughout the duration of the trial. This highlights the importance of psychological support alongside physical health management for chronic illness sufferers.

We assess health beyond traditional healthcare environments to gain a deeper insight into the burden of diseases. This holistic perspective on patient wellness reveals new business avenues by introducing innovative metrics for understanding disease and patient health. By cultivating a patient-focused comprehension of how diseases affect daily functioning, we can engage both physicians and payers more effectively while enhancing patient support initiatives. Furthermore, we aim to develop sophisticated algorithms that can forecast disease onset and its progression or regression, as well as pinpoint critical moments for intervention. Utilize actual digital data to advocate for the advantages of your offerings. Our technology-driven service facilitates real-world research that integrates unique, day-to-day behavioral information, thereby benefiting clinical, medical affairs, and commercial divisions, all while utilizing Evidation's virtual research site, Achievement. With adaptable study designs, strategies for device integration, and streamlined protocol management, we ensure efficient study operations. Additionally, we offer the flexibility for sponsorship either by us or your organization, allowing for tailored collaboration.

Accelerating the speed, precision, and affordability of cancer diagnoses is crucial, especially considering that one in three individuals will face this disease in their lifetime. Unfortunately, the current diagnostic process is often hindered by slow and costly methods, primarily due to the lack of advanced automated tools that support healthcare professionals. Qritive addresses this challenge by offering an AI-driven solution designed to assist physicians in analyzing both microscopy images and textual patient data efficiently. This innovation not only enhances the effectiveness of hospitals in diagnosing cancer but also contributes to significant cost savings. Additionally, Pantheon serves as a CE-marked, vendor-agnostic digital pathology platform that facilitates the complete digitization of pathology lab workflows and telepathology. It also supports comprehensive report generation and offers a robust platform for AI-driven analysis of whole-slide images in pathology. This technology is particularly adept at distinguishing between a variety of benign conditions and malignant diseases within breast tissue, which is vital for timely and accurate treatment. In doing so, it plays a pivotal role in transforming the landscape of cancer diagnostics.

Dynamic Health serves as a comprehensive, evidence-driven resource aimed at empowering nurses and allied health practitioners to enhance their skills, quickly find answers to clinical queries, and cultivate a commitment to evidence-based practices and critical analysis that ultimately leads to better patient care. The EBSCO team has expanded the already extensive content of Dynamic Health, now incorporating detailed discussions on evidence-based topics related to diseases and conditions, including their signs, symptoms, diagnostic tests, and care interventions, all tailored to meet the decision-making requirements of healthcare professionals. Furthermore, Dynamic Health simplifies the process of obtaining continuing education units (CEUs) through its integrated learning system, allowing users to earn credits while addressing clinical inquiries. This resource also provides a comprehensive overview of various diseases and conditions, along with valuable insights on abnormalities that may signify underlying medical issues, thereby enhancing the interprofessional team's ability to deliver quality care. By bridging the gap between knowledge and practice, Dynamic Health equips healthcare providers with the necessary tools to support informed decision-making and improve overall patient outcomes.

Rare diseases often lack comprehensive research, resulting in insufficient knowledge about essential elements for an effective drug discovery initiative. Our innovative AI platform, Healnet, addresses these issues by scrutinizing vast amounts of drug and disease data to uncover new connections that may lead to potential treatments. Utilizing cutting-edge technologies throughout the discovery and development process allows us to operate multiple phases simultaneously and on a large scale. The conventional approach of focusing on a single disease, target, and drug is overly simplistic, yet it remains the standard for most pharmaceutical companies. The future of drug discovery is driven by AI, characterized by parallel processes and an absence of rigid hypotheses, fundamentally integrating the three core paradigms of drug discovery into a cohesive strategy. This new paradigm not only enhances efficiency but also fosters creativity in developing solutions for complex health challenges.

Zebra's Imaging Analytics Engine processes imaging scans from multiple modalities and conducts automatic analyses of various clinical findings, ensuring efficiency and seamless integration with the radiology workflow. Healthcare providers rely on Zebra-Med to notify them about patients who are at elevated risk for cardiovascular, pulmonary, skeletal, and other health issues. This system enhances preventative care initiatives, supports accurate risk adjustments, and aids in meeting quality benchmarks like MACRA. By utilizing Zebra-Med, healthcare professionals can concentrate their efforts on the most vulnerable patients at critical moments, ultimately leading to reduced expenses and enhanced patient care outcomes. Consequently, this innovative approach not only improves the quality of care provided but also optimizes resource allocation across the healthcare system.

An AI-driven solution for public health screening utilizing X-Ray and CT scans focuses on detecting chest abnormalities such as Tuberculosis and infections similar to COVID-19. This advanced technology enhances X-ray imaging for identifying patterns associated with infectious diseases like TB and COVID-19, allowing for immediate prescreening and triage. We have refined the entire workflow to ensure that imaging assessment, diagnosis, and reporting are carried out without any complications. A smart notification system alleviates the pressure involved in the reporting process. The solution boasts three primary features: classifying, localizing, and quantifying lesions. By harnessing the power of Artificial Intelligence, we are committed to delivering prompt and efficient teleradiology services to the worldwide imaging community, ultimately improving patient outcomes and streamlining healthcare delivery.

Enhance your workforce's experience by providing customizable lifestyle benefits that alleviate stress, reclaim personal time, positively influence family life, and foster happiness. Streamline your operations and cut costs by integrating multiple vendors, stipends, and reimbursement systems into a user-friendly, automated platform. Fringe is the comprehensive solution for lifestyle benefits, employee wellness, recognition programs, peer-to-peer contributions, charitable employee donations, recruitment incentives, and a plethora of additional offerings. Leading organizations utilize Fringe to draw in and keep top talent, with clients experiencing a remarkable 50% reduction in turnover compared to their rivals by empowering their employees with options. Beyond just addressing mental and physical health, Fringe provides carefully selected benefits that encompass caregiver assistance, financial education, ongoing professional development, leisure activities, and much more. Employees who feel valued are not only more engaged but also more likely to remain loyal to their organization, making it essential to promote their wellbeing through a variety of choices. By prioritizing these personalized benefits, you can create a more motivated and satisfied workforce.

Grounded in established medical science and transparent systems biology, DARA enhances clinical decision-making and intervention strategies. Collaborating with healthcare providers and relevant stakeholders, we deliver digital solutions that revolutionize health screening and the management of chronic diseases. Our approach facilitates the digital evolution of care delivery through the automation of clinical workflows and the use of predictive analytics, all aligned with leading clinical guidelines and best practices. By offering actionable health insights through tailored predictions of disease risk and potential adverse events, we empower physicians to better connect with their patients. Additionally, we support pharmaceutical development by uncovering pharmacodynamics within intricate biological systems and discovering innovative therapeutic options. Utilizing predictive analytics on comprehensive patient data allows for personalized precision medicine, particularly in managing cardiometabolic diseases to avert severe patient outcomes. With our tools, healthcare can become more proactive and responsive, ultimately leading to improved patient care and health outcomes.